Correlation Between Franklin Wireless and Biodexa Pharmaceticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Franklin Wireless and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Wireless and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Wireless Corp and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Franklin Wireless and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Wireless with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Wireless and Biodexa Pharmaceticals.

Diversification Opportunities for Franklin Wireless and Biodexa Pharmaceticals

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Franklin and Biodexa is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Wireless Corp and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Franklin Wireless is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Wireless Corp are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Franklin Wireless i.e., Franklin Wireless and Biodexa Pharmaceticals go up and down completely randomly.

Pair Corralation between Franklin Wireless and Biodexa Pharmaceticals

Given the investment horizon of 90 days Franklin Wireless Corp is expected to generate 0.19 times more return on investment than Biodexa Pharmaceticals. However, Franklin Wireless Corp is 5.21 times less risky than Biodexa Pharmaceticals. It trades about 0.15 of its potential returns per unit of risk. Biodexa Pharmaceticals is currently generating about -0.03 per unit of risk. If you would invest  295.00  in Franklin Wireless Corp on October 9, 2024 and sell it today you would earn a total of  205.00  from holding Franklin Wireless Corp or generate 69.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Franklin Wireless Corp  vs.  Biodexa Pharmaceticals

 Performance 
       Timeline  
Franklin Wireless Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Wireless Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Franklin Wireless disclosed solid returns over the last few months and may actually be approaching a breakup point.
Biodexa Pharmaceticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biodexa Pharmaceticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Biodexa Pharmaceticals showed solid returns over the last few months and may actually be approaching a breakup point.

Franklin Wireless and Biodexa Pharmaceticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Franklin Wireless and Biodexa Pharmaceticals

The main advantage of trading using opposite Franklin Wireless and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Wireless position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.
The idea behind Franklin Wireless Corp and Biodexa Pharmaceticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance